Compare CVS Health Corp (CVS) vs Harmony Gold Mining Co. (HMY) Price & Performance

CVS Health trades at $95.67, down slightly by 0.03% today. The stock shows strong fundamental momentum with recent quarterly earnings beats, including Q2 2026 EPS of $2.58 versus $1.87 expected, and raised 2026 guidance. Valuation metrics appear reasonable with a P/E of 24.67 and P/S of 0.29. Technical indicators are mixed with a bullish overall signal but bearish moving averages, with key support at $95 and resistance at $96.

The outlook for CVS is positive, supported by earnings strength and analyst consensus, but risks include margin pressure and rising debt levels. The consensus price target of $115.90 implies significant upside, though investors should monitor execution on guidance and healthcare regulatory changes.

Harmony Gold Mining (HMY) trades at $19.90, up 0.96% with strong technical momentum as moving averages signal bullish alignment. The company demonstrates robust fundamentals with 2024 revenue of $61.38B and net income of $8.59B, achieving a 20.06% net margin. Recent earnings show mixed results with a Q4 2025 miss but strong operational cash flow growth to $15.65B in 2024. The stock's valuation remains reasonable with P/E of 12.26 and EV/EBITDA of 6.41, while the company transitions toward gold-copper diversification.

HMY presents a compelling value proposition with attractive profitability metrics and strategic diversification, though analyst sentiment remains cautious with 70% hold ratings. Key risks include gold price volatility and execution challenges in copper expansion. The stock trades near resistance at $20-21 with overbought RSI signals suggesting potential near-term consolidation before further upside.